Literature DB >> 758655

Late effects on the eye of conformation radiotherapy for carcinoma of the paranasal sinuses and nasal cavity.

K Morita, Y Kawabe.   

Abstract

Sixty patients with carcinoma of the paranasal sinuses and nasal cavity were treated with conformation radiotherapy technique (an improved moving-field technique). Only 28 were suitable for long-term follow-up with regard to eye complications. All patients receiving more than 5,800 rads in 6 weeks (1,700 reu in cumulative-radiation-effect dose) had strong panophthalmia with corneal ulceration within 2 years of radiotherapy. Of 21 eyes receiving 800--1,700 reu (2,800--5,400 rads in 6 weeks), 18 experienced visual disturbance from radiation cataracts and 3 equivocal changes at postirradiation intervals of 5 years. No patient receiving less than 800 reu (2,800 rads in 6 weeks) showed such complications.

Entities:  

Mesh:

Year:  1979        PMID: 758655     DOI: 10.1148/130.1.227

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Clinical-dosimetric relationship between lacrimal gland dose and ocular toxicity after intensity-modulated radiotherapy for sinonasal tumours.

Authors:  S S Batth; R Sreeraman; E Dienes; L A Beckett; M E Daly; J Cui; M Mathai; J A Purdy; A M Chen
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

2.  Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-Year Retrospective Study.

Authors:  Shubha Tiwari; Anusha Bhatt; Jayalaxmi Nagamodi; Mohammad Javed Ali; Hasnat Ali; Milind N Naik; Vijay Anand P Reddy; Geeta K Vemuganti
Journal:  Transl Vis Sci Technol       Date:  2017-06-15       Impact factor: 3.283

3.  Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer.

Authors:  Xiangjun Chen; Reza A Badian; Håvard Hynne; Cecilie Delphin Amdal; Bente Brokstad Herlofson; Øygunn Aass Utheim; Kristine Løken Westgaard; Fredrik Fineide; Janicke Liaaen Jensen; Tor Paaske Utheim
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.